A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma
- PMID: 22695087
- DOI: 10.1097/MPA.0b013e31823c9d21
A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma
Abstract
Objectives: MicroRNAs are molecules implicated in RNA-RNA interaction, playing a role in cell proliferation and differentiation, as well as in carcinogenesis. Knowledge on their biological features is necessary to understand their role in phenotypic characteristics of pancreatic adenocarcinoma.
Methods: Review of current literature concerning mechanisms of action, studying methods, implementations, and preclinical trials on pancreatic adenocarcinoma.
Results: More than 20 microRNAs have been identified, being involved in pancreatic adenocarcinoma biology, affecting tumor growth, metastatic potential, and chemosensitivity. Combinations of microRNAs can be used to differentiate between pancreatic adenocarcinoma and other pancreatic pathologies, as well as to assess prognosis. Manipulations of microRNAs can decrease the rate of growth or reinstall chemosensitivity to certain chemotherapeutic agents.
Conclusions: The field of microRNAs promises novel diagnostic and therapeutic tools in the management of pancreatic adenocarcinoma.
Similar articles
-
MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?Ann Surg Oncol. 2009 Nov;16(11):3183-9. doi: 10.1245/s10434-009-0623-1. Epub 2009 Jul 28. Ann Surg Oncol. 2009. PMID: 19636633 Review.
-
MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.Ann Surg Oncol. 2010 Dec;17(12):3120-8. doi: 10.1245/s10434-010-1188-8. Epub 2010 Jul 22. Ann Surg Oncol. 2010. PMID: 20652642
-
Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.Pancreas. 2011 Nov;40(8):1165-71. doi: 10.1097/MPA.0b013e3182218ffb. Pancreas. 2011. PMID: 22001830 Review.
-
MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues.Pancreatology. 2009;9(1-2):66-72. doi: 10.1159/000178876. Epub 2008 Dec 12. Pancreatology. 2009. PMID: 19077456 Review.
-
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.Oncogene. 2007 Jun 28;26(30):4442-52. doi: 10.1038/sj.onc.1210228. Epub 2007 Jan 22. Oncogene. 2007. PMID: 17237814
Cited by
-
Biomarkers in pancreatic adenocarcinoma: current perspectives.Onco Targets Ther. 2016 Dec 9;9:7459-7467. doi: 10.2147/OTT.S100510. eCollection 2016. Onco Targets Ther. 2016. PMID: 28003762 Free PMC article. Review.
-
Upregulation of MiR-196a promotes cell proliferation by downregulating p27kip1 in laryngeal cancer.Biol Res. 2016 Sep 27;49(1):40. doi: 10.1186/s40659-016-0100-9. Biol Res. 2016. PMID: 27678369 Free PMC article.
-
miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.Int J Mol Sci. 2023 Apr 13;24(8):7215. doi: 10.3390/ijms24087215. Int J Mol Sci. 2023. PMID: 37108374 Free PMC article.
-
MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.Oncotarget. 2017 Nov 18;8(64):107500-107512. doi: 10.18632/oncotarget.22494. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296182 Free PMC article.
-
MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.Semin Cancer Biol. 2019 Feb;54:63-71. doi: 10.1016/j.semcancer.2017.11.020. Epub 2017 Dec 2. Semin Cancer Biol. 2019. PMID: 29199014 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
